0001567619-23-005593.txt : 20230411 0001567619-23-005593.hdr.sgml : 20230411 20230411143931 ACCESSION NUMBER: 0001567619-23-005593 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230411 DATE AS OF CHANGE: 20230411 EFFECTIVENESS DATE: 20230411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rediscovery Life Sciences AKI LLC CENTRAL INDEX KEY: 0001681048 IRS NUMBER: 813174631 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-478495 FILM NUMBER: 23813174 BUSINESS ADDRESS: STREET 1: 8 CHURCH STREET CITY: CHARLESTON STATE: SC ZIP: 29401 BUSINESS PHONE: 703-915-4493 MAIL ADDRESS: STREET 1: 8 CHURCH STREET CITY: CHARLESTON STATE: SC ZIP: 29401 D 1 primary_doc.xml X0708 D LIVE 0001681048 Rediscovery Life Sciences AKI LLC 8 CHURCH STREET CHARLESTON SC SOUTH CAROLINA 29401 703-915-4493 DELAWARE None None Limited Liability Company true Patrick K. Donnelly c/o Resdicovery Life Sciences AKI LLC 8 Church Street Charleston SC SOUTH CAROLINA 29401 Director Richard Shea c/o Resdicovery Life Sciences AKI LLC 8 Church Street Charleston SC SOUTH CAROLINA 29401 Director Executive Officer Mr. Shea is the Chief Executive Office of the Issuer. David Adair c/o Resdicovery Life Sciences AKI LLC 8 Church Street Charleston SC SOUTH CAROLINA 29401 Director Rick Schnellmann c/o Resdicovery Life Sciences AKI LLC 8 Church Street Charleston SC SOUTH CAROLINA 29401 Director Executive Officer Mr. Schnellmann is the Chief Scientific Officer of the Issuer. Sunil Desai c/o Rediscovery Life Science AKI LLC 8 Church Street Charleston SC SOUTH CAROLINA 29401 Director Anita Watkins c/o Rediscovery Life Science AKI LLC 8 Church Street Charleston SC SOUTH CAROLINA 29401 Director Other Health Care Decline to Disclose 06b false 2023-03-27 false true true true Series B Preferred Units consisting of Series B Preferred Stock and Common Stock Unit Purchase Warrants. false 0 899985 449983 450002 false 22 0 0 0 false Rediscovery Life Sciences AKI LLC /s/ Richard Shea Richard Shea Chief Executive Officer of the Issuer 2023-04-11